Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immunocore Holdings (IMCR) Gains from Investment Securities (2019 - 2025)

Immunocore Holdings (IMCR) has disclosed Gains from Investment Securities for 7 consecutive years, with $6.2 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities rose 3836.08% to $6.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.6 million through Dec 2025, up 810.39% year-over-year, with the annual reading at $4.6 million for FY2025, 810.39% up from the prior year.
  • Gains from Investment Securities hit $6.2 million in Q4 2025 for Immunocore Holdings, up from -$527000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $11.6 million in Q4 2022 to a low of -$953000.0 in Q2 2024.
  • Historically, Gains from Investment Securities has averaged $1.4 million across 5 years, with a median of $80000.0 in 2024.
  • Biggest YoY gain for Gains from Investment Securities was 3836.08% in 2025; the steepest drop was 25550.0% in 2025.
  • Year by year, Gains from Investment Securities stood at $391818.2 in 2021, then soared by 2861.59% to $11.6 million in 2022, then tumbled by 105.45% to -$632000.0 in 2023, then soared by 125.0% to $158000.0 in 2024, then surged by 3836.08% to $6.2 million in 2025.
  • Business Quant data shows Gains from Investment Securities for IMCR at $6.2 million in Q4 2025, -$527000.0 in Q3 2025, and -$540000.0 in Q2 2025.